• Arrhythmias
• Heart Failure / LV dysfunction
• Valvular disease / Pulmonary circulation / Myocardial-Pericardial disease/ Congenital heart disease & Pediatric cardiology
• Ischaemia / CAD / ACC
• Interventions / Peripheral Circulation / Stroke / Surgery
• Prevention / Rehabilitation / Sports / Nursing
• Hypertension / Pharma
• Basic Science
• Cardiac Imaging / Computers

• Review evidence-based clinical studies to allow the clinician to better identify optimal candidates for implantable defibrillator therapy.
• Identify clinical attributes most predictive in identifying the best candidates with atrial fibrillation for catheter ablation therapy
• Review “CHADS2” scoring system in identifying patients at highest risk of thromboembolic stroke and consequent need for chronic anticoagulation
• Incorporate evidence-based clinical studies defining the role of cardiac resynchronization therapy (CRT) in patients with CHF

• Vascular Interventions
• Transcatheter Embolization
• Non-Vascular Interventions
• Interventional Oncology
• NEW: Neurointerventions
• Clinical Practice
• Imaging

• Over 50 World Renowned Speakers
• Scientific Abstract Oral and Poster Sessions
• Partnership relationships with the International Society of Obstetric Medicine Congress and the Royal Women`s Hospital Fetal Medicine Symposium. These events will bookend the ISSHP Congress.

• Clinical Trials
• Management and Therapeutics
• Biomarkers
• Long Term Outcomes
• Imaging
• Obesity and Metabolic Syndrome
• Thrombophilias
• Organ Dysfunctions
• Biochemical Pathways
• Fetal/Perinatal Outcomes
• Biochemical Pathways
• Fetal/Perinatal Outcomes
• Placentation
• Genomics
• Proteomics
• Metabolomics
• Molecular Studies
• Angiogenesis
• Oxidative Stress
• Inflammation
• Animal Studies
• Epidemiology

• Define and describe the epidemiology and pathophysiology of heart failure for optimal management of heart failure risk factors.
  
  
• Recognize and employ evidence-based heart failure management guidelines and treatment options to minimize complications for patients with heart failure.
  
  
• Identify and apply indications and contraindications for heart transplantation to better manage the evaluation and selection process for heart transplant candidates.
  
  
• Recognize and assess post heart transplant complications and use appropriate treatment options to balance the risks of both rejection and infection and minimize side effects of immunosuppressants.
  
  

• Implementing High-Dose Insulin Therapy for Patients with T2DM
  and Severe Insulin Resistance in Clinical Practice:
  Expert Recommendations and Practical Considerations
• The Science Behind Inflammation and Cardiometabolic Risk
• Inflammation and Cardiometabolic Risk:  Integrating the Science into Clinical Practice
• Genetics of Obesity
• Obesity/Lifestyle /Diet
• Obesity/Pharmacotherapy
• Obesity/Bariatric Surgery
• Sleep Apnea
• The Key Elements of Glucose Metabolism
• Should We Use Pharmacotherapy in Prediabetes
• Treatment of Type 2 Diabetes 2010
• Glycemic Control and Cardiovascular Disease
• Pediatric CVD Prevention
• Pediatric CVD Prevention
• CKD: A CHD Equivalent
• Vitamin D  and Cardiometabolic Risk
• ACC Case Study Session
• Advances in the Clinical Management of HDL
• Niacin vs. Fibrates in Patients with Metabolic Syndrome
• Clinical Controversies in Lipid Management
• Hot Topics in Thrombosis and Diabetes

• Evaluate and manage gastrointestinal complications of weight loss surgery.


• Evaluate pharmacologic treatment options for obese and overweight patients and the effect of 5 to 10 % weight loss on co-morbid conditions.


• Define lifestyle modification including physical activity as treatment for obesity, and activity recommendations for health and weight loss.


• Describe diabetes and other metabolic complications of obesity.


• Describe surgical treatment options for obesity and its effect on weight loss and co-morbid conditions.

• Recognize the aspects of the clinical presentation of patients with heart failure that are associated with successful outcomes after each mode of therapy is implemented.
• Interpret the results of the most recent trials in patients with non-ST segment elevation acute coronary syndromes and apply the appropriate level of aggressive treatment for each clinical presentation
• Describe recently developed treatment modalities for patients with severe aortic stenosis that have changed the paradigm for the assessment, follow up, and intervention in these patients.

• To increase knowledge and promote research about the diagnosis, causes, management and consequences of heart failure amongst health-care professionals with the intention of delaying or preventing the onset of heart failure and improving care for patients with heart failure.
  
• To provide expert advice to health-care professionals, patient or government organisations, including the National Health Service, when appropriate, and as requested.

• Sick Sinus Syndrome
  
• Atrial Fibrillation
  
• AV and Intraventricular Conduction Disturbances
  
• Sudden Death
  
• Non Invasive Sudden Death Risk Stratification
  
• Heart Failure
  
• Genetic Arrhythmias
  
• Hypertrophic Cardiomiopathy
  
• Arrhythmias in Diabetic Patients
  
• Sleep Apnea
  
• Cardiac Syncope
  
• Echocardiography in Arrhythmology
  
• Catheter Ablation Technique
  
• Implantable Pacing Devices and Leads
  
• New Automatic Algorithms for Detection and Pacing Optimization
  
• Cardiac Resynchronization Therapy
  
• Implantable Cardioverter-Defibrillators
  
  

• Next Generation DES
• Coronary Navigation and Guidance
• Innovation in Percutaneous Valvular Therapy
• Bifurcation Stenting
• Multidetector CT and Next Generation MR
• How to Succeed in Entrepreneurship in Medicine
• Device Based Heart Failure Interventions
• Structural Heart Disease: ASD/PFO/PDA
• Endovascular and Carotid Innovations
• Interventional Accessory Devices
• Acute MI
• CTO Club
• Innovation in Simulation
• Vulnerable Plaque Symposium
• Biotechnology and Cellular Engineering
• Structural and Functional Imaging of the Vulnerable Plaque
• Novel Stent Technologies

• Describe the recent advances in syncope diagnosis modalities.
• Apply appropriate follow-up strategies for patients with devices.
• Describe clinical treatment strategies for patients with syncope with respect to medications or non-pharmacologic therapies.
• Utilize risk stratification methodologies for cardiac arrest patients.
• Identify normal and adverse ant-iarrhythmic drug effects and device functions.

• List and compare the various methods for noninvasive diagnosis of vascular disease in the major testing areas of cerebrovascular, venous, peripheral arterial, and visceral vascular
• Discuss the role of the vascular laboratory in vascular disease screening
• Understand the current status of catheter-directed thrombolysis for deep venous thrombosis
• Discuss the role of the vascular laboratory in the management of deep vein thrombosis
• Understand the vascular laboratory evaluation for chronic venous insufficiency
• Be familiar with current issues in vascular laboratory billing, credentialing, and accreditation
• Discuss the current status of endovascular treatment for abdominal aortic aneurysms and thoracic aortic disease
• Be familiar with the pre- and post-procedure evaluation of patients having abdominal aortic endografts
• Discuss the various approaches to imaging of the renal, visceral, and peripheral arteries
• Explain the role of duplex ultrasound for follow-up of arterial interventions and surveillance of bypass grafts
• Understand the current status of endovascular intervention for femoropopliteal disease
• Describe and analyze issues related to interpretation and reporting of vascular laboratory tests
• Review the physical principles of Doppler spectral analysis and color-flow imaging

• Learn more about how to use coping strategies with your stroke patients
• Increase your knowledge about the brain`s plasticity and ability to rebuild damaged parts
• New methods and evidence for cognitive rehabilitation of stroke patients
• Deepen your knowledge of patients with neglect
• Listen to how to reintegrate young stroke patients who are in my life

•    Pulmonary atresia-intact ventricular septum with coronary fistulas or sinusoids present,
•    Hypoplastic left heart syndrome with coronary artery fistulas or sinusoids present,
•    Anomalous pulmonary origin of coronary artery,
•    Anomalous aortic origin of coronary artery,
•    Aortopulmonary window,
•    Aortico-left ventricular tunnel, and 
•    Congenital cardiac disease associated with tracheal stenosis.

• Identify new diagnostic and therapeutic interventional technologies for the treatment of patients with complex coronary artery disease
  
• List novel pharmacological therapies for the treatment of patients with coronary artery disease before, during and following coronary intervention  
  
• Explain the results of recently published clinical trials
  
• Describe the short and long term benefits of percutaneous and surgical revascularization modalities in patients with multivessel and complex coronary artery disease
  
• Report recent advances in heart and vascular imaging including CT, MRI, near infrared spectroscopy and sonographic modalities 
  

• A comprehensive overview of the biomarkers and genetic basis of chronic heart failure and hypertension
  
• Insights into the lifestyle risks, preventative measures and complications of hypertension
  
• A review of the current and emerging pharmacotherapies for hypertension and understanding of the ways in which patient adherence to therapies can be improved
  
• An update on the optimal clinical assessment and diagnostic strategies for chronic heart failure
  
• Understanding of the association between chronic heart failure and renal disease
  
• Assessments of current and novel therapies for chronic heart failure including pharmacotherapies, cardiac resynchronisation therapies and mechanical assist devices
  
• An opportunity to share and exchange ideas with leading practitioners in the field
  

• "HOT TOPICS" IN THE PACEMAKERS AND DEVICE THERAPY
  
• GENETIC SCREENING: WHAT SHOULD KNOW The cardiologist?
  
• MODERN TREATMENT OPTIONS FOR THE REDUCTION OF CARDIOVASCULAR RISK
• INNOVATIVE APPROACHES PHARMACOLOGICAL THERAPY IN CARDIOLOGY
• INNOVATIVE APPROACHES PHARMACOLOGICAL THERAPY IN CARDIOLOGY
• CURRENT STANDARDS IN HEART FAILURE
  

• Preventing Cardiovascular
• Myocardial infarction
• Arterial hypertension
• Diabetes
• Obesity

• About the association of cardiovascular risk factors and diagnosis with emotional symptoms and problems;
• The impact of a cardiovascular episode or problem on the effected person’s partner and other close significant others;
• The interplay between stress and distress and coronary difficulties, and;
• How to intervene more effectively utilizing a collaborative, integrative, psycho-cardiology understanding and treatment regimen

• Live cases featuring procedures by skilled operators and accompanied by commentary from expert panelists
• Networking opportunities with international colleagues
• Heated debates that stimulate important discussion- no chair throwing allowed!
• Course directors and faculty renowned in the field and offering statistics from, insight on and analyses of the latest studies
• In-depth, focused sessions that provide meaningful opportunities to increase understanding of clinical issues that impact practice
• Lunchtime case reviews of coronary and peripheral interventions with interactive audience discussions
• Workshops on evolving interventional technologies
• The Concepts in Contemporary Cardiovascular Medicine Symposium is an ideal learning opportunity for cardiologists, cardiac and vascular surgeons, interventional radiologists and cardiac critical care nurses.

• Reviewing natural histories of patients with common isolated, pure valvular lesions.
• Discussing and reviewing predictors of outcomes with and without surgery for common valve lesions.
• Presenting and evaluating currently-accepted criteria for surgical intervention.
• Discussing evolving concepts of pharmacological therapy in patients with valvular lesions.
• Discussing and reviewing current standards for echocardiographic evaluation of valvular diseases — including technical problems and their solutions and considering the roles of newer imaging modalities.
• Discussing and reviewing current technical approaches to difficult problems in valve surgery.
• Describing techniques and expected outcomes of valve repair.
• Reviewing current strategies for preventing of thrombo-embolic events in patients with valve diseases.
• Reviewing current data concerning percutaneous valve repair and replacement.
• Reviewing current concepts regarding management of infective endocarditis

• Cardiovascular Diseases.
• Pediatric Cardiology.
• Cardiac Surgery.
• Cardiac Anesthesia.

• Pregnancy and cardiovascular diseases
• Coronary heart disease in the female patient
• Coronary heart disease in the female patient
• Special aspects in the cardiovascular diagnosis of the female patient

• Acute heart failure (diagnosis, pathophysiology, other)
• Acute heart failure (therapy)
• Animal models & experimentation
• Arrhythmias and treatment
• Atrial fibrillation
• Beta blockers
• Cancer / Cardiotoxicity
• Cardiac resynchronisation (CRT) therapy
• Cardiomyopathy
• Cardio-Renal Syndrome
• Cell Signalling
• Cellular biology & cellular electrophysiology
• Co-morbidities (incl COPD, anaemia, cachexia)
• Cytokines and inflammation
• Diagnosis of HF & Biomarkers
• Disease management & Patient education
• Diuretics & Fluid Status/Management
• Drug therapy, other
• Echocardiography
• Exercise testing & training
• Gene and cell therapy
• Haemodynamics / coronary & peripheral circulation
• Heart transplantation  / Assist Devices
• Hormones / neurohumoral regulation
• Hypertension / LV hypertrophy
• ICD therapy
• Imaging: MRI, CT, Nuclear cardiology
• Ischemia / Reperfusion / Preconditioning
• Left ventricular function
• Metabolism / Diabetes mellitus
• Molecular biology / genetics
• Natriuretic peptides
• Nursing
• Other
• Pathophysiology
• Population studies / Epidemiology
• Prognosis (other)
• Prognosis (using biomarkers)
• Psychosocial / ethical concepts / education
• Pulmonary hypertension
• Renin-angiotensin-aldosterone antagonists & Diuretics
• Surgery (CABG, valvular, artificial heart, other)
• Telemedicine & E-Health
• Vascular biology, other

• Acute Cardiac care
• Cardiac imaging
• Cardiovascular prevention
• Cardiovascular pharmacology and drug therapy
• cardiac arrythmias
• Surgery
• Heart failure
• Genetics
• Hypertension
• and more...

• Atrial Septal Defects (ASD)
• Sinus Venosus Defect
• Congenital VSD´s
• Pulmonary and Coronary Fistula
• Patent Ductus

• Patent Foramen Ovale
• Post-MI VSD
• HOCM
• Left Atrial Appendage Closure

• Percutaneous Aortic Valve Replacement
• Valvuloplasty
• Paravalvular Leak Closure
• Percutaneous Mitral Valve Repair

• How to Close Atrial and Ventricular Septal Defects
• How to use Balloons and Stents in Coarctation and Pulmonary Artery Stenoses
• How to Close Large Patent Ductus and Pulmonary AV Fistulae

• How and When to Close Patent Foramen Ovale to Prevent Paradoxical Embolism
• How to Close Post Myocardial Infarction Ventricular Septal Defects
• How to Close the Left Atrial Appendage to Prevent Embolic Stroke in Atrial Fibrillation
• How to Treat Heart Failure by Catheter Techniques

• How to Close Paravalvular Leaks
• How to Repair Heart Valves by Catheter Techniques
• How to Implant Heart Valves Percutaneously
• How to Perform a Valvuloplasty

• Developmental and cellular biology
• Genes and metabolism
• Hypertrophy, cell cycle, stem cells
• Growth factors, neurohormones and signal transduction
• Ion channels and electrophysiology
• Excitation,  excitation-contraction coupling
• Ischaemia and protection, oxygen
• Circulation, vascular biology
• Lipids, atherosclerosis 
•  Integrative mechanisms and approaches